NYSE - Delayed Quote USD

Medifast, Inc. (MED)

26.69 +0.76 (+2.93%)
At close: May 3 at 4:00 PM EDT
26.84 +0.15 (+0.56%)
After hours: 8:00 PM EDT
Loading Chart for MED
DELL
  • Previous Close 25.93
  • Open 26.29
  • Bid 25.76 x 2200
  • Ask 27.50 x 1100
  • Day's Range 25.36 - 26.81
  • 52 Week Range 25.36 - 109.52
  • Volume 452,479
  • Avg. Volume 439,875
  • Market Cap (intraday) 291.914M
  • Beta (5Y Monthly) 1.15
  • PE Ratio (TTM) 4.31
  • EPS (TTM) 6.19
  • Earnings Date Apr 29, 2024
  • Forward Dividend & Yield 6.60 (24.73%)
  • Ex-Dividend Date Sep 18, 2023
  • 1y Target Est 25.00

Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.

medifastinc.com

634

Full Time Employees

December 31

Fiscal Year Ends

Recent News: MED

Performance Overview: MED

Trailing total returns as of 5/3/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

MED
60.29%
S&P 500
7.50%

1-Year Return

MED
68.51%
S&P 500
24.47%

3-Year Return

MED
86.73%
S&P 500
22.64%

5-Year Return

MED
77.54%
S&P 500
75.76%

Compare To: MED

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MED

Valuation Measures

Annual
As of 5/3/2024
  • Market Cap

    291.92M

  • Enterprise Value

    156.06M

  • Trailing P/E

    4.31

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.33

  • Price/Book (mrq)

    1.38

  • Enterprise Value/Revenue

    0.17

  • Enterprise Value/EBITDA

    1.66

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    7.55%

  • Return on Assets (ttm)

    16.44%

  • Return on Equity (ttm)

    35.49%

  • Revenue (ttm)

    897.81M

  • Net Income Avi to Common (ttm)

    67.76M

  • Diluted EPS (ttm)

    6.19

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    156.43M

  • Total Debt/Equity (mrq)

    9.75%

  • Levered Free Cash Flow (ttm)

    56.58M

Research Analysis: MED

Company Insights: MED

Research Reports: MED

People Also Watch